Campaigners make final appeal to HSE over Skyclarys drug
Campaigners advocating for those affected by Friedreich's Ataxia have again appealed to the HSE to approve the Skyclarys treatment ahead of a final decision next week.
We haven't written up this one. RTE News has the full story — the link below goes straight to it.